| Guidance Title: | Venetoclax in combination with rituximab for treating relapsed or refractory chronic lymphocytic leukaemia |
| Guidance Type: | NICE Technology Appraisal |
| Expected Date: | Feb 2019 |
| Guidance Title: | Venetoclax in combination with rituximab for treating relapsed or refractory chronic lymphocytic leukaemia |
| Guidance Type: | NICE Technology Appraisal |
| Expected Date: | Feb 2019 |